Human Reproduction, Vol. 16, No. 10, 2243-2244,
October 2001
© 2001 European Society of Human Reproduction and Embryology
Letters to the Editor |
Mifepristone (RU486) and voluntary termination of pregnancy: enigmatic variations* or anecdotal religion-based attitudes?
1 Inserm and Collège de France, Pincus Building, 80 rue du Général Leclerc 94276 Le Kremlin-Bicêtre, France 2 Department of Obstetrics and Gynecology, Chaim Sheba Medical Center 52621 Tel-Hashomer, Israel 3 1, rue de la Mosquée, Marsa Plage 2070 Tunis, Tunisia
Dear Sir,
Mifepristone (RU486), the first clinically efficient antiprogesterone (Herrmann et al., 1982
; Baulieu, 1989
), has made the concept of medical abortion a reality (Ulmann et al., 1992
). Here we only refer to the voluntary termination of early pregnancy, which sustains so much controversy in the vast and evolving domain of women's reproductive health (Van Look, 2000
). Legally on the market for years in France, Britain and Sweden and massively produced and used in China, the compound has become available to women in need in
Notes
References